Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer

Documenti analoghi

• The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
  di: Anna Han, et al.
  Pubblicazione: (2024)
• EXPRESSION OF CONCERN: Combination Cisplatin and Sulforaphane Treatment Reduces Proliferation, Invasion, and Tumor Formation in Epidermal Squamous Cell Carcinoma
  Pubblicazione: (2024)
• The mechanism of RGS5 regulating gastric cancer mismatch repair protein
  di: Zhenwei Yang, et al.
  Pubblicazione: (2024)
• γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
  di: Hao Zhu, et al.
  Pubblicazione: (2024)
• LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
  di: Banglun Pan, et al.
  Pubblicazione: (2024)